搜索页_nther+G+Steger

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Opening Hours
Collections
Help Via Email

Electronic Information Resources

常用资源

内部出版物

CNKI会议论文(1)

CNKI学位论文(11)

知网期刊论文(8)

在“Elsevier电子期刊”中，命中：5条，耗时：小于0.01 秒

在所有数据库中总计命中：20条

1.Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial

作者：Prof Christoph Zielinski ; MD^a ; ^{christoph.zielinski@meduniwien.ac.at" class="auth_mail" title="E-mail the corresponding author} ; Prof Istvá ; n Lá ; ng ; MD^b ; Prof Moshe Inbar ; MD^c ; Prof Zsuzsanna Kahán ; MD^d ; Prof Richard Greil ; MD^e ; Prof Semir Beslija ; MD^f ; Salomon M Stemmer ; MD^g ; Zanete Zvirbule ; MD^h ; Gü ; nther G Steger ; MD^a ; Prof Bohuslav Melichar ; MDⁱ ; Tadeusz Pienkowski ; MD^j ; Daniela Sirbu ; MD^k ; Prof Lubo&scaron ; Petruzelka ; MD^l ; Alexandru Eniu ; MD^m ; Bella Nisenbaum ; MDⁿ ; Prof Magdalena Dank ; MD^o ; Prof Rodica Anghel ; MD^p ; Diethelm Messinger ; MSc^q ; Thomas Brodowicz ; MD^a ; for the TURANDOT investigators^&dagger ;

刊名：The Lancet Oncology

出版年：2016

2.Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy

作者：Regina Promberger¹ ; ² ; Peter Dubsky¹ ; ^{peter.dubsky@meduniwien.ac.at" class="auth_mail" title="E-mail the corresponding author} ; Martina Mittlbö ; ck³ ; Johannes Ott² ; Christian Singer² ; Rudolf Seemann⁴ ; Ruth Exner¹ ; Peter Panhofer¹ ; Gü ; nther Steger⁵ ; Elisabeth Bergen⁵ ; Michael Gnant¹ ; Raimund Jakesz¹ ; Zsuzsanna Bago-Horvath⁶ ; Margaretha Rudas⁶ ; Rupert Bartsch⁵

关键词：CMF ; Neoadjuvant chemotherapy ; Pathologic complete response ; Postneoadjuvant chemotherapy ; Survival

刊名：Clinical Breast Cancer

出版年：2015

3.Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

作者：Prof Istvan Lang ; MD^a ; Thomas Brodowicz ; MD^b ; Larisa Ryvo ; MD^c ; Prof Zsuzsanna Kahan ; MD^d ; Prof Richard Greil ; MD^e ; Semir Beslija ; MD^f ; Salomon M Stemmer ; MD^g ; Bella Kaufman ; MD^h ; Zanete Zvirbule ; MDⁱ ; Gü ; nther G Steger ; MD^b ; Prof Bohuslav Melichar ; MD^j ; Tadeusz Pienkowski ; MD^k ; Daniela Sirbu ; MD^l ; Diethelm Messinger ; MSc^m ; Prof Christoph Zielinski ; MD^b ; ^{christoph.zielinski@meduniwien.ac.at} ; on behalf of the Central European Cooperative Oncology Group ^&dagger ;

刊名：Lancet Oncology

出版年：2013

4.Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro

作者：Kristina K. Schö ; nau ; Gü ; nther G. Steger ; Robert M. Mader

关键词：Colon cancer ; Endothelial cells ; Chemoresistance ; Cancer pharmacology

刊名：Cancer Letters

出版年：2007

5.Resistance to 5-Fluorouracil

作者：Mader ; Robert M. ; Mü ; ller ; Markus ; Steger ; Gü ; nther G.

关键词：5-fluorouracil ; resistance ; metabolism ; RNA processing ; apoptosis

刊名：General Pharmacology

出版年：1998

1

按检索点细分(5)

作者(5)

按出版年细分(5)

2016年(1)

2015年(1)

2013年(1)

2007年(1)

2000年及以前(1)

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.